Catecholamine-dependent hereditary Cushing's syndrome - Follow-up after unilateral adrenalectomy;Katecholaminabhängiges hereditäres Cushing-syndrom - Verlaufsbeobachtung nach einseitiger adrenalektomie

Medizinische Klinik

Volumn 97, Issue 12, 2002, Pages 747-753

  Imöhl, Matthias ^a,b   Köditz, Roland ^a   Stachon, Axel ^a   Müller, Klaus Michael ^a   Nicolas, Volkmar ^b   Pfeilschifter, Johannes ^a   Krieg, Michael ^a  

^a ST JOSEF HOSPITAL   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

ACTH independent; Bilateral macronodular hyperplasia of the adrenal cortex; Follow up; Hereditary; Normalization of pathologic findings; Unilateral adrenalectomy

Indexed keywords

BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE; CORTICOTROPIN; DEXAMETHASONE; HYDROCORTISONE;

ADRENAL GLAND; ADRENAL HYPERPLASIA; ADRENALECTOMY; ADRENERGIC STIMULATION; ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CUSHING SYNDROME; DIAGNOSTIC TEST; FAMILIAL DISEASE; FOLLOW UP; GENETIC DISORDER; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; MALE; RECEPTOR BLOCKING;

ADRENAL CORTEX; ADRENAL CORTEX FUNCTION TESTS; ADRENALECTOMY; ADRENOCORTICOTROPIC HORMONE; ADULT; CATECHOLAMINES; CUSHING SYNDROME; DEXAMETHASONE; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROCORTISONE; HYPERPLASIA; MALE;

RAPHIA FRATER;

EID: 0037115225     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00063-002-1220-2     Document Type: Article

References (55)

1. Aiba M. Cushing's syndrome due to huge bilateral adrenocortical multinodular hyperplasia - ACTH-independent bilateral adrenocortical macronodular hyperplasia (AIMAH). Nippon Naibunpi Gakkai Zasshi 1994;70:37-42.
2. Aiba M, Hirayama A, Iri H, et al. Adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia as a distinct subtype of Cushing's syndrome. Enzyme histochemical and ultrastructural study of four cases with a review of the literature. Am J Clin Pathol 1991:96:334-40.
3. Anding K, Kohler G, Bohm N, Petersen KG, Schollmeyer P, Neumann HP. Primary pigmented nodular adrenocortical dysplasia. A rare cause of Cushing's syndrome. Dtsch Med Wochenschr 1996;121:1321-4.
4. Arce B, Licea M, Hung S, Padron R. Familial Cushing's syndrome. Acta Endocnnol (Copenh) 1978;87:139-47.
5. Bornstein SR, Chrousos GP. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: Neural and immune inputs. J Clin Endocrinol Metab 1999;84:1729-36.
6. Bourdeau I, Stratakis CA. Cyclic AMP-dependent signaling aberrations in macronodular adrenal disease. Ann N Y Acad Sci 2002;968:240-55.
7. Chabre O, Liakos P, Vivier J, et al. Cushing's syndrome due to a gastric inhibitory polypeptide-dependent adrenal adenoma: Insights into honnonal control of adrenocortical tumorigenesis. J Clin Endocrinol Metab 1998;83:3134-43.
8. Choi KM, Seu JH, Kim YH, et al. Cushing's syndrome due to primary pigmented nodular adrenocortical disease - A case report reviews of the literature. Korean J Intern Med 1995;10:68-72.
9. Cugi P, Letizia C, Di Palma L, Scavo D. Primary adrenocortical nodular dysplasia, a distinct subtype of Cushing's syndrome. Am J Med 1987;82:189-90.
10. Daidoh H, Morita H, Hanafusa J, et al. In vivo and in vitro effects of AVP and V1 a receptor antagonist on Cushing's syndrome due to ACTH-independent bilateral macronodular adrenocortical hyperplasia. Clin Endocrinol (Oxf) 1998;49:403-9.
11. De Herder WW, Hofland LJ, Usdin TB, et al. Food-dependent Cushing's syndrome resulting from abundant expression of gastric inhibitory polypeptide receptors in adrenal adenoma cells. J Clin Endocrinol Metab 1996;81:3168-72.
12. Donaldson MD, Grant DB, O'Hare MJ, Shackleton CH. Familial congenital Cushing's syndrome due to bilateral nodular adrenal hyperplasia. Clin Endocrinol (Oxf) 1981;14:519-26.
13. Doppman JL, Chrousos GP, Papanicolaou DA, Stratakis CA, Alexander HR, Nieman LK. Adrenocorticotropin-independent macronodular adrenal hyperplasia: An uncommon cause of primary adrenal hypercortisolism. Radiology 2000;216:797-802.
14. Dralle H, et al. Leitlinien zur chirurgischen Therapie von Nebennierenerkrankungen. Grundlagen der chirurgie, G92. Mittlg Dtsch Ges Chir 2000:4. Beilage.
15. Findlay JC, Sheeler LR, Engeland WC, Aron DC. Familial adrenocorticortropin-independent Cushing's syndrome with bilateral macronodular adrenal hyperplasia. J Clin Endocrinol Metab 1993;76:189-91.
16. Gardner DF, Barlascini CO, Downs RW, Sahni KS. Cushing's disease in two sisters. Am J Med Sci 1989;297:387-9.
17. Hingshaw HT, Ney RL. Abnormal control in the neoplastic adrenal cortex. In: McKerns KW, ed. Hormones and Cancer. New York: Academic Press, 1974:309-27.
18. Horiba N, Suda T, Aiba M, et al. Lysine vasopressin stimulation of cortisol secretion in patients with adrenocorticotropin-independent macronodular adrenal hyperplasia. J Clin Endocrinol Metab 1995;80:2336-41.
19. Iida K, Kaji H, Matsumoto H, et al. Adrenocorticotrophin-independent macronodular adrenal hyperplasia in a patient with lysine vasopressin responsiveness but insensitivity to gastric inhibitory polypeptide. Clin Endocrinol (Oxf) 1997;47:739-45.
20. Irie J, Kawai K, Shigematsu K, et al. Adrenocorticotropic hormone-independent bilateral macronodular adrenocortical hyperplasia associated with Cushing's syndrome. Pathol Int 1995;45:240-6.
21. Iseli BE, Hedinger CE. Histopathology and ultrastructure of primary adrenocortical nodular dysplasia with Cushing's syndrome. Histopathology 1985;9:1171-94.
22. Jabbar A, Grant D, Savage M, Grossman A. Primary pigmented nodular adrenocortical dysplasia: A rare form of a rare disorder. J R Soc Med 1994;87:110-1.
23. Joffe SN, Brown C. Nodular adrenal hyperplasia and Cushing's syndrome. Surgery 1983;94:919-25.
24. Koch CA, Bornstein SR, Chrousos GP, Stratakis CA. Primary pigmented nodular adrenocortical dysplasia (PPNAD) within the scope of Carney complex as the etiology of Cushing syndrome. Med Klin 2000;95:224-30.
25. Kohler G, Anding K, Bohm N. Primary pigmented nodular adrenocortical dysplasia. Pathol Res Pract 1998;194:201-4.
26. Lacroix A, Bolte E, Tremblay J, et al. Gastric inhibitory polypeptide-dependent cortisol hypersecretion - A new cause of Cushing's syndrome. N Engl J Med 1992;327:974-80.
27. Lacroix A, Mircescu H, Hamet P. Clinical evaluation of the presence of abnormal hormone receptors in adrenal Cushing's syndrome. Endocrinologist 1999;9:9-15.
28. Lacroix A, N'Diaye N, Mircescu H, Hamet P, Tremblay J. Abnormal expression and function of hormone receptors in adrenal Cushing's syndrome. Endocr Res 1998;24:835-43.
29. Lacroix A, N'Diaye N, Tremblay J, Hamet P. Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. Endocr Rev 2001;22:75-110.
30. Lacroix A, Tremblay J, Rousseau G, Bouvier M, Hamet P. Propranolol therapy for ectopic beta-adrenergic receptors in adrenal Cushing's syndrome. N Engl J Med 1997;337:1429-34.
31. Lacroix A, Tremblay J, Touyz RM, et al. Abnormal adrenal and vascular responses to vasopressin mediated by a V1-vasopressin receptor in a patient with adrenocorticotropin-independent macronodular adrenal hyperplasia, Cushing's syndrome, and orthostatic hypotension. J Clin Endocrinol Metab 1997;82:2414-22.
32. Lamas C, Alfaro JJ, Lucas T, Lecumberri B, Barcelo B, Estrada J. Is unilateral adrenalectomy an alternative treatment for ACTH-independent macronodular adrenal hyperplasia? Long-term follow-up of four cases. Eur J Endocrinol 2002;146:237-40.
33. Larsen JL, Cathey WJ, Odell WD. Primary adrenocortical nodular dysplasia, a distinct subtype of Cushing's syndrome. Case report and review of the literature. Am J Med 1986;80:976-84.
34. Malchoff CD, Rosa J, DeBold CR, et al. Adrenocorticotropin-independent bilateral macronodular adrenal hyperplasia: An unusual cause of Cushing's syndrome. J Clin Endocrinol Metab 1989;68:855-60.
35. Matsukura S, Kakita T, Fukase M, Fujita T. Adenylate cyclase of a human medullary thyroid carcinoma. Experientia 1981;37:523-4.
36. Matsukura S, Kakita T, Hirata Y, Yoshimi H, Fukase M. Adenylate cyclase of GH and ACTH producing tumors of human: Activation by non-specific hormones and other bioactive substances. J Clin Endocrinol Metab 1977;44:392-7.
37. McArthur RG, Bahn RC, Hayles AB. Primary adrenocortical nodular dysplasia as a cause of Cushing's syndrome in infants and children. Mayo Clin Proc 1982;57:58-63.
38. Miki T, Nakayama J, Shimizu K, et al. ACTH-independent bilateral macronodular adrenocortical hyperplasia (AIMAH): A case report. Hinyokika Kiyo 1999;45:245-8.
39. Miyajima A, Nakashima J, Tachibana M, Baba S, Nakamura K, Murai M. ACTH-independent bilateral macronodular adrenocortical hyperplasia caused Cushing's syndrome. Urol Int 1997;58:259-61.
40. Monnerat R, Pesqueira D, Comesana E, et al. Cushing syndrome caused by macronodular hyperplasia ACTH-independent. Actas Urol Esp 1996;20:384-7.
41. Morioka M, Ohashi Y, Watanabe H, et al. ACTH-independent macronodular adrenocortical hyperplasia (AIMAH): Report of two cases and the analysis of steroidogenic activity in adrenal nodules. Endocr J 1997;44:65-72.
42. N'Diaye N, Hamet P, Tremblay J, Boutin JM, Gaboury L, Lacroix A. Asynchronous development of bilateral nodular adrenal hyperplasia in gastric inhibitory polypeptide-dependent Cushing's syndrome. J Clin Endocrinol Metab 1999;84:2616-22.
43. Nemoto Y, Aoki A, Katayama Y, et al. Non-cushingoid Cushing's syndrome due to adrenocorticotropic hormone-independent bilateral adrenocortical macronodular hyperplasia. Intern Med 1995;34:446-50.
44. Nomata K, Sakai H, Suzuki S, et al. Proliferating cell nuclear antigen in ACTH-independent bilateral macronodular adrenal hyperplasia. Int J Urol 1995;2:203-5.
45. Reznik Y, Allali-Zerah V, Chayvialle JA, et al. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide. N Engl J Med 1992;327:981-6.
46. Sasao T, Itoh N, Sato Y, Takahashi A, Tsukamoto T. Subclinical Cushing syndrome due to adrenocorticotropic hormone-independent macronodular adrenocortical hyperplasia: Changes in plasma cortisol levels during long-term follow-up. Urology 2000;55:145.
47. Schorr I, Hinshaw HT, Cooper MA, Mahaffee D, Ney RL. Adenyl cyclase hormone responses of certain human endocrine tumors. J Clin Endocrinol Metab 1972;34:447-51.
48. Shenoy BV, Carpenter PC, Carney JA. Bilateral primary pigmented nodular adrenocortical disease. Rare cause of the Cushing syndrome. Am J Surg Pathol 1984;8:335-44.
49. Stratakis CA, Carney JA, Kirschner LS, et al. Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: Neuroendocrine properties of tumors associated with Carney complex. J Clin Endocrinol Metab 1999;84:1122-8.
50. Teding VB, Croughs RJ, Kater L, et al. Familial Cushing's syndrome due to nodular adrenocortical dysplasia. A putative receptor-antibody disease? Clin Endocrinol (Oxf) 1986;24:299-310.
51. Terzolo M, Boccuzzi A, Ali A, et al. Cushing's syndrome due to ACTH-independent bilateral adrenocortical macronodular hyperplasia. J Endocrinol Invest 1997;20:270-5.
52. Wada N, Kubo M, Kijima H, et al. Adrenocorticotropin-independent bilateral macronodular adrenocortical hyperplasia: Immunohistochemical studies ofsteroidogenic enzymes and post-operative course in two men. Eur J Endocrinol 1996;134:583-7.
53. Yamada Y, Sakaguchi K, Inoue T, et al. Preclinical Cushing's syndrome due to adrenocorticotropin-independent bilateral adrenocortical macronodular hyperplasia with concurrent excess of gluco- and mineralocorticoids. Intern Med 1997;36:628-32.
54. Young WF, Carney JA, Musa BU, Wulffraat NM, Lens JW, Drexhage HA. Familial Cushing's syndrome due to primary pigmented nodular adrenocortical disease. Reinvestigation 50 years later. N Engl J Med 1989;321:1659-64.
55. Zeiger MA, Nieman LK, Cutler GB, et al. Primary bilateral adrenocortical causes of Cushing's syndrome. Surgery 1991;110:1106-15.